Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania.
With more than 20 years in the biopharmaceutical industry, Anu has previously held various roles at Genentech, a member of the Roche Group. Prior to joining Genentech, Anu held various roles at Eli Lilly and Company and at Bristol-Myers Squibb (formerly Dupont Pharmaceuticals Company) across R&D, quality and QC.
Anu brings with her extensive experience of discovering, developing and licensing both bio and pharmaceutical product for global markets with specific emphasis on managing multiple tech transfers, execution in manufacturing, regulatory submissions, filings, and licensures.
Anu received her Ph.D. in Molecular Biophysics at UT Southwestern Medical Center in Dallas, Texas and a M.S. in Biochemistry from the University of Delaware.
About Abzena
Abzena is a leading partner research organization which offers discovery, design, development and cGMP manufacture of biologics, bioconjugates and complex or highly potent small molecules to the global biopharmaceutical industry. From its facilities in the UK and US the company provides its customers with concept to clinic solutions. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors.
